Reference : New rationales for using TGFbeta inhibitors in radiotherapy.
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
http://hdl.handle.net/2268/160655
New rationales for using TGFbeta inhibitors in radiotherapy.
English
Andarawewa, Kumari L. [> >]
Paupert, Jenny mailto [Lawrence Berkeley National Laboratory > > > >]
Pal, Anupama [> >]
Barcellos-Hoff, Mary Helen [> >]
2007
International Journal of Radiation Biology
83
11-12
803-11
Yes (verified by ORBi)
International
0955-3002
1362-3095
England
[en] Ataxia Telangiectasia Mutated Proteins ; Cell Cycle Proteins/metabolism ; DNA Damage ; DNA-Binding Proteins/metabolism ; Humans ; Models, Biological ; Neoplasms/drug therapy/genetics/metabolism/radiotherapy ; Radiation Tolerance/drug effects/physiology ; Radiobiology ; Signal Transduction/drug effects/physiology/radiation effects ; Transforming Growth Factor beta/antagonists & inhibitors/metabolism ; Tumor Suppressor Proteins/antagonists & inhibitors/metabolism
[en] PURPOSE: The first reports that ionizing radiation (IR) induces rapid and persistent activation of transforming growth factor beta1 (TGFbeta) were nearly two decades ago. Subsequent studies have shown that TGFbeta is a major mediator of cellular and tissue responses to IR and have revealed novel facets of its complex biology. RESULTS: We and others have recently shown that inhibition of production or signaling of TGFbeta in epithelial cells modulates radiosensitivity and impedes activation of the DNA damage response program. The primary transducer of cellular response to DNA damage caused by ionizing radiation is the nuclear protein kinase ataxia telangiectasia mutated, whose activity is severely compromised when TGFbeta is inhibited. Thus, in conjunction, with its well-recognized contribution to normal tissue fibrosis, the role of TGFbeta in the genotoxic stress program provides a previously unsuspected avenue to modulate radiotherapy. CONCLUSIONS: We hypothesize that identification of the circumstances and tumors in which TGFbeta manipulation enhances tumor cell radiosensitivity, while protecting normal tissues, could significantly increase therapeutic index.
http://hdl.handle.net/2268/160655
10.1080/09553000701711063

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
paupert int j radiat biol.pdfPublisher postprint258.73 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.